These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15789668)

  • 1. The metabolic syndrome: modify root causes, treat risk factors.
    Rassman J; Gupta S
    JAAPA; 2005 Mar; 18(3):30-6; quiz 37-8. PubMed ID: 15789668
    [No Abstract]   [Full Text] [Related]  

  • 2. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein distribution in the metabolic syndrome, type 2 diabetes mellitus, and familial combined hyperlipidemia.
    Ayyobi AF; Brunzell JD
    Am J Cardiol; 2003 Aug; 92(4A):27J-33J. PubMed ID: 12957324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome and risk of stroke.
    Brown WV
    Clin Cornerstone; 2004; 6 Suppl 3():S30-4. PubMed ID: 15707267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome: is it a syndrome? Does it matter?
    Kahn R
    Circulation; 2007 Apr; 115(13):1806-10; discussion 1811. PubMed ID: 17404171
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolic syndrome: diabetes and cardiovascular disease.
    Gupta S; Gupta BM
    Indian Heart J; 2006; 58(2):149-52. PubMed ID: 18989060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin treatment in patients with metabolic syndrome and coronary artery disease.
    Ishihara M
    Circ J; 2009 Nov; 73(11):2013-4. PubMed ID: 19851028
    [No Abstract]   [Full Text] [Related]  

  • 8. Adolescent BMI and risk of diabetes versus coronary disease.
    de Oliveira JM; Lisboa LB
    N Engl J Med; 2011 Jun; 364(26):2558; author reply 2559. PubMed ID: 21714667
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dyslipidemia management in patients with impaired glucose tolerance].
    Asano M; Yamada N
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():538-42. PubMed ID: 15779437
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolic syndrome.
    Twedell D
    J Contin Educ Nurs; 2006; 37(4):150-1. PubMed ID: 16892664
    [No Abstract]   [Full Text] [Related]  

  • 11. [Statin treatment in type 2 diabetes. Is it a must today?].
    Faust M
    MMW Fortschr Med; 2003 Feb; 145(9):35-6. PubMed ID: 12666527
    [No Abstract]   [Full Text] [Related]  

  • 12. Should the insulin resistance syndrome be treated in the elderly?
    Grant RW; Meigs JB
    Drugs Aging; 2004; 21(3):141-51. PubMed ID: 14979733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy for metabolic syndrome].
    Node K
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1737-41. PubMed ID: 17037308
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of treatment to increase HDL-cholesterol and decrease triglyceride concentrations in prevention of coronary heart disease in Type 2 diabetes.
    Wild S; Byrne CD
    Diabet Med; 2004 Sep; 21 Suppl 4():8-11. PubMed ID: 15315518
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of statins on the vasculature: Implications for aggressive lipid management in the cardiovascular metabolic syndrome.
    Sowers JR
    Am J Cardiol; 2003 Feb; 91(4A):14B-22B. PubMed ID: 12615294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggressively preventing diabetes.
    Schrier RW
    Nat Rev Nephrol; 2010 Jun; 6(6):313. PubMed ID: 20508667
    [No Abstract]   [Full Text] [Related]  

  • 17. Nicotinic acid and HDL-C reduction.
    S Afr Med J; 2005 Feb; 95(2):89. PubMed ID: 15751197
    [No Abstract]   [Full Text] [Related]  

  • 18. On the road to better dyslipidemia outcomes.
    Hughes S
    Nurse Pract; 2009 Feb; 34(2):14-21; quiz 22. PubMed ID: 19155874
    [No Abstract]   [Full Text] [Related]  

  • 19. Nicotinic acid in the management of dyslipidaemia associated with diabetes and metabolic syndrome: a position paper developed by a European Consensus Panel.
    Shepherd J; Betteridge J; Van Gaal L;
    Curr Med Res Opin; 2005 May; 21(5):665-82. PubMed ID: 15969866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.
    Breuer HW
    Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.